Maxelon Pharmaceuticals Private Limited
About Maxelon Pharmaceuticals Private Limited
Data last updated:
Maxelon Pharmaceuticals Private Limited is a private limited company based in Naini, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2019PTC121307. Its GSTIN is 09AAMCM9470B1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.57 Lakh. It is led by directors including Rajnish Kumar and Abhishek Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 161 E/4 Kazipur, Naini, Uttar Pradesh, India – 211008.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.23 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹33,862 (net margin 1.1%) and EBITDA of ₹1.1 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 106% over three years.
As per MCA filings, the company has open charges of ₹4 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address161 E/4 Kazipur, Naini, Uttar Pradesh, India – 211008
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxelon Pharmaceuticals Private Limited
The main business activity of Maxelon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxelon Pharmaceuticals Private Limited FY 2025 filings available
Maxelon Pharmaceuticals Private Limited reported revenue of ₹30.23 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxelon Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 106% over three years, including 5% growth in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxelon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33,862 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxelon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxelon Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Maxelon Pharmaceuticals Private Limited
Maxelon Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajnish Kumar Also directs: Dyraa Pharmaceutical India Private Limited | Director | 02 Apr 2025 | 1 Years 6 Months | Current |
| Abhishek Mishra | Director | 12 Mar 2021 | 5 Years 7 Months | Current |
| Amit Mishra | Director | 16 Sep 2019 | 7 Years 1 Months | Current |
Peer Comparison of Maxelon Pharmaceuticals Private Limited
Maxelon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Macnis Pharmaceuticals Private Limited | ₹30.55 Lakh (FY 2023) | •••• | •••• | 27.0% | •••• | Delhi, India |
| Keryx Pharmaceuticals Private Limited | ₹30.46 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Mohali, Punjab, India |
| Ackrose Pharmaceuticals Private Limited | ₹30.44 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Delhi, India |
| Bioclinical Pharmaceuticals Private Limited | ₹30.41 Lakh (FY 2022) | •••• | •••• | 47.0% | •••• | Pune, Maharashtra, India |
| Strebi Pharmaceuticals Private Limited | ₹30.4 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Jagadhari, Haryana, India |
| Maxelon Pharmaceuticals Private Limited this company | ₹30.23 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Naini, Uttar Pradesh, India |
| Thebes Pharmaceuticals Private Limited | ₹30.2 Lakh (FY 2025) | •••• | •••• | 58.0% | •••• | New Delhi, Delhi, India |
| Yera Pharmaceuticals Private Limited | ₹30.2 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Giniva Pharmaceuticals Private Limited | ₹30.19 Lakh (FY 2024) | •••• | •••• | -30.0% | •••• | Ellisbridge, Ahmedabad, Gujarat, India |
| Rubra Pharmaceuticals Limited | ₹30.15 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Telangana, India |
| Mildness Pharmaceuticals Private Limited | ₹30.09 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Garhpura, Bihar, India |
Peers are the five companies nearest above and the five nearest below Maxelon Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Maxelon Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxelon Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2024 | Others | ₹4 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Maxelon Pharmaceuticals Private Limited
Maxelon Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxelon Pharmaceuticals Private Limited
Maxelon Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Rajnish Kumar was appointed as Director on 02 Apr 2025.
Credit Ratings, Litigation & Regulatory Alerts for Maxelon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxelon Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxelon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxelon Pharmaceuticals Private Limited
Maxelon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCM9470B1Z6 | Uttar Pradesh | Active | 08 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxelon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxelon Pharmaceuticals Private Limited
Maxelon Pharmaceuticals is an active private limited company based in Naini, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 16 September 2019 (7+ years old) and is registered under CIN U51909UP2019PTC121307.
Maxelon Pharmaceuticals reported revenue of ₹30.23 Lakh for FY 2025 (up 5% YoY).
Maxelon Pharmaceuticals has 3 current directors:
- Rajnish Kumar - Director
- Abhishek Mishra - Director
- Amit Mishra - Director
Maxelon Pharmaceuticals reported a net profit of ₹33,862 (net margin 1.1%) and EBITDA of ₹1.1 Lakh (EBITDA margin 3.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxelon Pharmaceuticals is 106% over three years. In the latest year (FY 2025) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxelon Pharmaceuticals is 09AAMCM9470B1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Maxelon Pharmaceuticals is U51909UP2019PTC121307. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxelon Pharmaceuticals was incorporated on 16 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Maxelon Pharmaceuticals by revenue are Macnis Pharmaceuticals Private Limited, Keryx Pharmaceuticals Private Limited, Ackrose Pharmaceuticals Private Limited, Bioclinical Pharmaceuticals Private Limited, Strebi Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rajnish Kumar was appointed as Director on 02 Apr 2025. Ashutosh Tiwari ceased to be Director on 16 Aug 2023. Chandan Singh Yadav ceased to be Director on 12 Oct 2021. Maxelon Pharmaceuticals has 5 board changes on record in total.
The registered office of Maxelon Pharmaceuticals is at 161 E4 Kazipur, Naini, Uttar Pradesh, India – 211008.